Elanco Animal Health Incorporated Common Stock (NY:ELAN)

Elanco Animal Health (NYSE:ELAN) Soars After Strong Q1 Beat, Raises Full-Year Outlook ↗

Topics Economy

Today 7:27 EDT

Via Chartmill

Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates

Today 6:37 EDT

Animal health company Elanco (NYSE:ELAN) announced better-than-expected revenue in Q1 CY2026, with sales up 14.9% year on year to $1.37 billion. The company ...

Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors should know. Elanco beat analysts’ r...

Topics Earnings

Elanco (ELAN) Q1 Earnings: What To Expect

May 04, 2026

Elanco Animal Health Inc (NYSE:ELAN) Reports Strong Q4 Earnings Beat and Confirms 2026 Guidance ↗

Topics Artificial Intelligence

February 24, 2026

Via Chartmill

Topics Earnings

Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks

April 22, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN) and its peers. The pharmaceuti...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Topics Artificial Intelligence Intellectual Property

3 Mid-Cap Stocks Walking a Fine Line

April 13, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

April 06, 2026

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

Topics Artificial Intelligence

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Topics Government Stocks

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

March 23, 2026

Elanco’s 26.6% return over the past six months has outpaced the S&P 500 by 23.6%, and its stock price has climbed to $23.47 per share. This was partly thanks...

Topics Artificial Intelligence

Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?

March 12, 2026

Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know

Topics Stocks

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier

Topics Economy Government World Trade

March 02, 2026

The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that...

Shares of animal health company Elanco (NYSE:ELAN) jumped 8.2% in the morning session after the company reported fourth-quarter results that surpassed Wall Street's expectations, with investors...

Topics Economy

Why Is Elanco (ELAN) Stock Soaring Today

February 24, 2026

Elanco (ELAN) Q4 2025 Earnings Call Transcript

Topics Artificial Intelligence

Elanco (ELAN) Q4 2025 Earnings Call Transcript ↗

February 24, 2026

Animal health company Elanco (NYSE:ELAN) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 12.2% year on year to $1.14 billion. Guidance for next quarter’s revenue was...

Topics Earnings Economy

Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales

February 24, 2026

Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Tuesday before market open. Here’s what you need to know.

What To Expect From Elanco’s (ELAN) Q4 Earnings

February 22, 2026

Why a $104 Million Allocation to Eagle Materials Stock Could Signal Confidence in Construction’s Next Cycle ↗

February 14, 2026

This U.S. supplier serves construction and packaging markets with a diverse mix of cement, aggregates, wallboard, and paperboard.

Why a $183 Million Bet on FTI Consulting Signals Upside Potential Amid a 16% One-Year Drop ↗

Topics Regulatory Compliance Supply Chain

February 14, 2026

FTI Consulting provides business advisory services worldwide, specializing in transformation, risk mitigation, and dispute resolution.

NICE Stock Down 38.5% as One Fund Dumps $32.75 Million. Here's What Investors Should Know ↗

February 14, 2026

This enterprise software provider delivers cloud-based AI solutions for customer engagement, compliance, and financial crime prevention.

Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,...

Topics Artificial Intelligence Regulatory Compliance

Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market

February 12, 2026

Via Finterra

Topics Artificial Intelligence Earnings Economy

1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

February 11, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border

February 05, 2026

In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Topics Death Economy

2 Profitable Stocks to Own for Decades and 1 Facing Headwinds

January 26, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

3 Mid-Cap Stocks with Open Questions

January 25, 2026

The past six months have been a windfall for Elanco’s shareholders. The company’s stock price has jumped 64.6%, setting a new 52-week high of $23.81 per share. This was partly thanks to its solid...

3 Reasons to Avoid ELAN and 1 Stock to Buy Instead

January 06, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

1 Stock Under $50 on Our Buy List and 2 We Find Risky

December 28, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Topics Economy

3 Hyped Up Stocks with Warning Signs

December 24, 2025

Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025

December 24, 2025

As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D...

In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another...

Topics Bonds Earnings World Trade

Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment

December 24, 2025